Associate Professor at University of Nottingham.
Novel animal model of Alzheimer’s (T30).

Professor of Neuropharmacology at Oxford Brookes University.
Target engagement: characterisation of the binding of the peptide and drugs on the alpha7 nicotinic receptor.

Associate Professor in Chemical-Biology and Director of the Centre for Global Infectious Diseases at Durham University.
Drug discovery: peptoid and peptide chemistry to tackle interesting and challenging biological problems. He is a valued member of our Drug Risk Task Force.

Professor of Medicine and Neurology at University of California, Los Angeles
Alzheimer’s: Proof of concept and characterisation of NBP14 in pathology

Professor of Neuroscience at University of Oxford
Parkinson’s: Effects of T30 and NBP14 on dopamine release ex vivo.

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with pathology

Clinical Senior Lecturer in Neurology at Queens Mary, University of London
ALS: Relation of plasma T14 to pathology.

Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with AD pathology.

Non-Clinical Lecturer at Sheffield University
ALS: Effects of T30 and NBP14 in zebrafish model.